Related Experiment Videos
Ropivacaine.
A Casati1, R Santorsola, E Cerchierini
1Università Vita e Salute, Dipartimento di Anestesiologia, IRCCS H. San Raffaele, Milan, Italy.
Minerva Anestesiologica
|January 5, 2002
Summary
Ropivacaine offers effective and safe regional anesthesia with less toxicity than bupivacaine. This long-acting local anesthetic provides differential sensory and motor blockade, making it a valuable alternative for various procedures and pain management.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Ropivacaine is a long-acting local anesthetic, a pure S(-) isomer with high pKa and low lipid solubility.
- Its properties allow for differential sensory and motor blockade and lower toxicity compared to other agents.
- This review evaluates ropivacaine's indications and benefits in regional anesthesia.
Purpose of the Study:
- To evaluate the existing literature on ropivacaine's use in regional anesthesia.
- To assess its indications and advantages across various anesthetic techniques.
Main Methods:
- Systematic review of prospective, randomized, controlled trials.
- Evaluation of ropivacaine's clinical application in epidural, spinal, and peripheral nerve blocks.
Main Results:
- Ropivacaine demonstrates efficacy and safety in epidural and peripheral nerve blocks (single-shot and continuous).
- Studies indicate efficacy and safety for spinal anesthesia, despite lack of registration.
- Intrathecal ropivacaine shows potential for outpatient procedures due to its pharmacodynamics.
Conclusions:
- Ropivacaine provides differential sensory-motor blockade, especially at low concentrations for postoperative analgesia.
- It offers comparable efficacy to bupivacaine with reduced cardiotoxicity and CNS toxicity.
- Ropivacaine is a safer alternative to bupivacaine for nerve blocks and postoperative pain management.